Results 211 to 220 of about 22,677 (265)
Some of the next articles are maybe not open access.

Protracted tolbutamide hypoglycemia

The American Journal of Medicine, 1963
Abstract Three cases of prolonged tolbutamide-induced hypoglycemia are reported. Four additional cases, with hypoglycemia greater than twenty-four hours duration, are collected from the literature. The high mortality rate may result, in part, from clinical unfamiliarity with this complication of tolbutamide administration.
P, CUSHMAN   +3 more
openaire   +2 more sources

Tolbutamide-induced Hemolytic Anemia

Diabetes, 1977
A 67-year-old female diabetic is presented who developed a Coombs'-positive hemolytic anemia after a year of treatment with tolbutamide. An IgG antibody was identified in the patient's serum that caused the agglutination of both the patient's red blood cells and tolbutamide-coated erythrocytes in the absence of complement. Such a reaction did not occur
P, Malacarne   +3 more
openaire   +2 more sources

CHOLESTATIC JAUNDICE FROM TOLBUTAMIDE

Annals of Internal Medicine, 1960
Excerpt The list of chemicals capable of producing hepatic injury grows in disturbingly direct proportion to the number of drugs introduced into the pharmacy.
R W, BAIRD, J G, HULL
openaire   +2 more sources

Tolbutamide and Truth

Annals of Internal Medicine, 1971
Excerpt To the editor: Dr. Schwartz's article on the tolbutamide controversy (ANNALS75:303-306, 1971) is revealing in its presentation of the moral dilemmas that face the physician-researcher.
openaire   +2 more sources

Tolbutamide: Men from Mars

Annals of Internal Medicine, 1971
Excerpt To the editor: Dr. Schwartz's account, "The Tolbutamide Controversy: A Personal Perspective" (Ann Intern Med75:303-306, 1971), is a valuable insight for the thousands of us who do not speci...
G F, Brockmann, T B, Schwartz
openaire   +2 more sources

Prolonged Tolbutamide-Induced Hypoglycemia

JAMA: The Journal of the American Medical Association, 1963
THE VALUE of the sulfonylurea compounds as effective hypoglycemic agents, with a relatively low incidence of side effects, has been well established. However, prolonged hypoglycemia accompanying the use of these agents in diabetic, as well as nondiabetic, patients recently has been emphasized.
R, CHERNER, C W, GROPPE, J J, RUPP
openaire   +2 more sources

Home - About - Disclaimer - Privacy